Trillium Therapeutics Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of Trillium Therapeutics Inc. on 31/03/2021 amounted to 0 $. The dynamics of net income of Trillium Therapeutics Inc. has changed by -124 520 000 $ in recent years. These are the main financial indicators of Trillium Therapeutics Inc.. The financial schedule of Trillium Therapeutics Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report chart shows the values from 30/06/2017 to 31/03/2021. The value of "net income" Trillium Therapeutics Inc. on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-10 862 000 $
-
31/12/2020
33 000 $
-
113 658 000 $
-
30/09/2020
0 $
-100 % ↓
-12 507 000 $
-
30/06/2020
115 000 $
+238.24 % ↑
30 553 000 $
-
30/09/2019
131 000 $
-
-12 598 000 $
-
30/06/2019
34 000 $
-
-6 495 000 $
-
31/03/2019
0 $
-
-10 679 000 $
-
31/12/2018
0 $
-
-8 553 000 $
-
30/09/2018
0 $
-
-13 052 000 $
-
30/06/2018
0 $
-
-12 316 000 $
-
31/03/2018
0 $
-
6 633 592.50 $
-
31/12/2017
0 $
-
8 474 921.86 $
-
30/09/2017
0 $
-
9 139 209.18 $
-
30/06/2017
0 $
-
8 978 368.99 $
-
Show:
to
Trillium Therapeutics Inc. financial report charts
The latest dates of Trillium Therapeutics Inc. financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Trillium Therapeutics Inc. is 31/03/2021. Operating income Trillium Therapeutics Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Trillium Therapeutics Inc. is -11 314 000 $
Trillium Therapeutics Inc. quarterly report dates
Net income Trillium Therapeutics Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Trillium Therapeutics Inc. is -10 862 000 $ Current assets Trillium Therapeutics Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Trillium Therapeutics Inc. is 286 041 000 $ Total assets Trillium Therapeutics Inc. refers to the total amount of assets owned by a person or entity. Total assets Trillium Therapeutics Inc. is 288 288 000 $
Current cash Trillium Therapeutics Inc. - the sum of all of the cash a company has on the date of report. Current cash Trillium Therapeutics Inc. is 247 905 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
33 000 $
-
115 000 $
131 000 $
34 000 $
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
33 000 $
-
115 000 $
131 000 $
34 000 $
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
131 000 $
34 000 $
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-11 314 000 $
-19 878 000 $
-12 994 000 $
-25 254 000 $
-9 557 000 $
-11 758 000 $
-10 931 000 $
-11 491 000 $
-11 852 000 $
-13 969 000 $
8 031 565 $
8 798 556.05 $
7 451 958.16 $
7 353 657.21 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-10 862 000 $
113 658 000 $
-12 507 000 $
30 553 000 $
-12 598 000 $
-6 495 000 $
-10 679 000 $
-8 553 000 $
-13 052 000 $
-12 316 000 $
6 633 592.50 $
8 474 921.86 $
9 139 209.18 $
8 978 368.99 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
5 801 000 $
10 162 000 $
7 476 000 $
7 793 000 $
8 310 000 $
10 707 000 $
10 092 000 $
11 285 000 $
10 752 000 $
12 722 000 $
7 234 604.50 $
7 801 412.87 $
6 670 808.50 $
6 826 118.71 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
11 314 000 $
19 911 000 $
12 994 000 $
25 369 000 $
9 688 000 $
11 792 000 $
10 931 000 $
11 491 000 $
11 852 000 $
13 969 000 $
-8 031 565 $
-8 798 556.05 $
-7 451 958.16 $
-7 353 657.21 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
286 041 000 $
298 529 000 $
296 277 000 $
133 444 000 $
37 433 000 $
44 390 000 $
54 028 000 $
47 541 000 $
54 377 000 $
67 494 000 $
58 728 786 $
66 333 081.40 $
52 886 814.70 $
57 223 607.62 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
288 288 000 $
300 822 000 $
298 776 000 $
135 162 000 $
40 342 000 $
52 041 000 $
62 429 000 $
55 459 000 $
63 059 000 $
76 962 000 $
66 637 980 $
75 066 433.51 $
62 421 838.62 $
67 225 352.38 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
247 905 000 $
247 600 000 $
237 260 000 $
72 869 000 $
16 307 000 $
14 365 000 $
40 369 000 $
20 832 000 $
12 101 000 $
23 626 000 $
22 779 594 $
22 551 816.37 $
22 672 687.50 $
29 031 924.27 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
14 069 000 $
12 951 000 $
11 764 000 $
13 356 000 $
12 560 000 $
14 094 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
57 251 040 $
65 037 749.47 $
51 832 383.58 $
56 007 191.67 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
15 687 000 $
15 277 000 $
19 627 000 $
13 858 000 $
13 764 000 $
15 333 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
38.89 %
29.36 %
31.44 %
24.99 %
21.83 %
19.92 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
257 287 000 $
263 149 000 $
257 112 000 $
45 578 000 $
-8 733 000 $
3 376 000 $
3 882 000 $
-6 008 000 $
1 686 000 $
10 614 000 $
54 724 621 $
62 482 073.09 $
52 171 768.52 $
58 157 315.58 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-6 961 000 $
-8 978 000 $
-10 986 000 $
-8 448 000 $
-10 869 000 $
-10 467 000 $
-7 366 269.50 $
-5 240 170.30 $
-5 113 817.61 $
-4 117 321.97 $
Last revenue report of Trillium Therapeutics Inc. was 31/03/2021. According to last financial report total revenue in Trillium Therapeutics Inc. was 0 US dollar and changed by -100% since last year. Net income in Trillium Therapeutics Inc. was -10 862 000 $ in last quartal, net income changes to 0%.
Trillium Therapeutics Inc. stocks data
TRIL stock price
Trillium Therapeutics Inc. stock price today, TRIL stock quote.
